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Background:Mucins are excellent candidates for contributing to the presence of meconium ileus (MI) in cystic ﬁbrosis (CF) due to their extensive
genetic variation and known function in intestinal physiology. The length of variants in mucin central repetitive regions has not been explored as
“risk” factors for MI in CF.
Methods:We investigated the length polymorphisms in the central repetitive regions of MUC1, MUC2, and MUC5AC by Southern blot and tested
for association with MI in CF subjects.
Results: No signiﬁcant associations were found for the allele sizes of any of the genes with respect to the prevalence of MI (p values = 0.33, 0.16,
and 0.71 for MUC1, MUC2, and MUC5AC, respectively).
Conclusions: The genetic length variants in the central repetitive region of three MUC genes studied are not associated with MI in subjects with
CF.
© 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Meconium ileus; Genetic modiﬁer; MUC1; MUC2; MUC5AC1. Introduction
Meconium ileus (MI) occurs in 15–20% of cystic fibrosis
(CF) subjects with pancreatic insufficiency, which is defined as
an intestinal obstruction with thick meconium in newborns [1,2].
MI is thought to be under little influence of environmental factors,
so it is likely to reflect genetic variation [1,3–6]. Genetic variants
in several genes and genomic loci have been associated with the
MI phenotype in different CF populations, including ADIPOR2,
MSRA, SLC4A4, SLC6A14, and SLC26A9, and also at loci on
chr4q35.1, chr11q25, chr20p11.22, and chr21q22.3 [3–6]. Due to☆ Prior publication disclosure: There are no related manuscripts in press or
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and MI in CF. Pediatr Pulm 2008; 43(S31):275) reporting a subset of subjects.
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regions and structural variations are not included in panels used
for genome wide association studies (GWAS).
Mucins are key components of mucus, which is the front-line
host defense system in the gastrointestinal tract. Enterocytes
are covered by secreted and transmembrane mucins, such as
MUC1, MUC2 and MUC5AC [7,8]. Additionally, MUC1 could
modulate the expression of other mucins in the small intestine, as
demonstrated in the CF/Muc1−/− transgenic mice [9]. MUC1 and
MUC5AC/Muc5ac have also been reported to play important
roles in inflammatory bowel diseases and intestinal nematode
infection [8,10–12]. MUC2/Muc2 are known to contribute to
severe colitis and colon cancer [13,14]. The MUC1, MUC2 and
MUC5AC length polymorphisms in the core region, described
here as the “central repetitive region” (previously referred to as
the “variable number tandem repeat (VNTR) region” [15–17]),
have been demonstrated to show association between a specific
MUC5AC allele and severity of CF lung disease [17]. Length
variation of the central repetitive region may affect the propertiesll rights reserved.
614 X. Guo et al. / Journal of Cystic Fibrosis 13 (2014) 613–616and functions of the intestinal mucus, and therefore, we tested to
see if these variants influence the susceptibility of MI in a large
CF population.2. Methods
This study was conducted in accordance with the approval
of the Institutional Review Board from the University of North
Carolina at Chapel Hill. CF subjects with known meconium
ileus (MI) status confirmed through source documents at birth,
or a compatible history of MI plus evidence of an abdominal
scar (if primary records were unobtainable), were included [6].
CF subjects with good quality DNA samples (N50 kb on average)
were selected [17]. The study was limited to Caucasians to
minimize population stratification; only Phe508del homozygous
subjects were included in the noMI group to eliminate the impact
of the CFTR genotype. The main characteristics are summarized
in Table 1.
To assess the allele sizes in the central repetitive region for
MUC1,MUC2, andMUC5AC, Southern blotting ofHinfI-digested
genomic DNA was performed as described previously [15,17].
Differences of the allele size distribution in the central repetitive
region, between MI and no MI CF groups, were analyzed by
the non-parametricWilcoxon rank-sum test (Intercooled Stata 10;
StataCorp, College Station, TX).3. Results
3.1. Allele distributions and association with MI
MUC1 allele sizes ranged from 2.6 to 8.0 kb. The distribution
was bimodal, with two common peaks around 3.6 and 5.6/5.7 kb.
There was no significant association between the overall allele
size and the MI phenotype (p value = 0.33), nor was there any
obvious trend distinguished between the MI and no MI groups
(Fig. 1A).
MUC2 allele sizes ranged from 3.7 to 10.7 kb; however, the
majority of alleles were between 5.9 and 7.2 kb, centering at the
6.7 kb allele. Although alleles N6.7 kb tended to bemore common
in the MI group, there was no significant difference between the
two groups (p value = 0.16) (Fig. 1B).
MUC5AC alleles ranged from 5.6 to 8.5 kb, with a major peak
at 6.3/6.4 kb, and aminor one at 6.9 kb. There was no association
of the allele distribution between the two groups (p value = 0.71)
(Fig. 1C).Table 1
Clinical characteristics of CF patients with and without meconium ileus (MI).
Gene MUC1
Phenotype MI no MI
Subjects, n 138 373
Age range, yrs 5.7–50.8 8.1–52.1
Mean age, yrs ± SD 20.2 ± 8.7 23.9 ± 10.0
Male (%) 74 (53.6) 193 (51.7)
CFTR homozygous Phe508del (%) 117 (84.8) 373 (100)3.2. Additional MUC2 association analysis
Additional tests were performed for MUC2 to search for any
insight into the trend in association. Neither males nor females
showed a significant association (p value = 0.18 and 0.48,
respectively; data not shown) with MI. For 216 CF subjects with
severe lung disease [17], a trend for larger alleles was noted to be
more common in the MI group than those in the no MI group (p
value = 0.08; data not shown). For the 317 CF subjects with mild
lung disease, there was no association (p value = 0.93; data not
shown).
Finally, we tested MUC2 association with MI by CFTR
genotype, but noted no association for Caucasian homozygous
Phe508del CF subjects for MI versus no MI (p value = 0.13;
data not shown).
4. Discussion
The central repetitive region of the major intestinal mucins is a
key factor in determining the molecular weight and glycosylation
status of the mucins [7,15,16,18]; thus, we hypothesized that
length polymorphisms may be associated withMI in CF subjects.
In a CF Phe508del homozygous mouse model, the small
intestinal mucus layer is denser and less penetrable, compared
to that of normal mice [19]. MUC2 is the most abundant mucin of
the intestinal mucus, and one study using a mouse model showed
that Muc2 (via its O-glycosylation) was vital in determining
the Salmonella infection status and the function of the intestinal
epithelial barrier [13]. MUC1 is up-regulated and poorly
glycosylated in colonic tissue from children with inflammatory
bowel disease [10]. Several studies have also reported that
MUC5AC plays an important role in inflammatory bowel disease
[8,11].
Our work made use of previous protocols [15,17] that had
several key features: 1) relatively large numbers of CF subjects
in both MI and no MI groups; 2) CFTR genetic homogeneity of
subjects; 3) gender balance for defining length polymorphisms;
and 4) well-optimized Southern blot techniques with maximal
resolution and minimal gel-to-gel variation [17]. This study did
not demonstrate any significant association among the length
variants in the central repetitive region of MUC1, MUC2, and
MUC5AC with the presence of MI in CF subjects, and our
negative MUC2 association is consistent with the ulcerative
colitis disease report [20]. Our data demonstrate that the studied
genetic variants do not influence the formation of MI directly in
CF subjects, even though these variants could possibly affect
properties of intestinal mucus. However, we cannot exclude thatMUC2 MUC5AC
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Fig. 1. Distribution of allele size in the central repetitive region of MUC1, MUC2, and MUC5AC by the MI phenotype. The number of alleles in the MI or no MI
groups is given followed by the Wilcoxon rank-sum test p value. The proportion of alleles for MI and no MI were not significant for (A) MUC1 (p value = 0.33),
(B)MUC2 (p value = 0.16), nor (C)MUC5AC (p value = 0.71). For easier viewing, theMUC1 alleles 2.6–2.9 kb were binned together and shown as a bar b 3.0 and
6.1–8.0 kb were binned as N 6.0 (A). Similarly,MUC2 alleles 3.7–5.8 kb were binned as b5.9 and 7.3–10.7 kb were grouped as N7.2 (B). Finally,MUC5AC alleles
5.6–6.1 kb were binned as b6.2 and 7.1–8.5 kb were binned as N7.0 (C).
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